From the 1Departments of Medicine and Obstetrics & Gynecology, University of Michigan, Ann Arbor, MI; 2The Biostatistics Center, George Washington University, Rockville, MD; 3Department of Medicine, Albert Einstein College of Medicine, New York, NY; 4Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Denver, CO; 5Department of Medicine, University of Tennessee, Memphis, TN; 6Department of Epidemiology, University of Colorado, Denver, CO; 7Department of Medicine, University of Texas Health Science Center, San Antonio, TX; 8Department of Medicine, University of Colorado, Denver, CO; 9Department of Epidemiology and Biostatistics, George Washington, University, Rockville, MD; and 10Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA.
Received October 8, 2010; revised and accepted December 1, 2010.
Funding/support: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study: collection, management, analysis, and interpretation of the data. The Southwestern American Indian Centers were supported directly by the NIDDK and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, supported the data collection at many of the clinical centers. Funding for data collection and participant support were also provided by the National Institute of Child Health and Human Development, the National Institute on Aging, the Office of Research on Women's Health, the Office of Research on Minority Health, the Centers for Disease Control and Prevention, and the American Diabetes Association. Bristol-Myers Squibb and Parke-Davis provided medication. This research was also supported, in part, by the intramural research program of the NIDDK. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under a subcontract with the Coordinating Center. The project described was supported by Award Number U01DK048489 from the NIDDK; C.K. was supported by NIDDK K23DK071552.
Financial disclosure/conflicts of interest: None reported.
The opinions expressed are those of the investigators and do not necessarily reflect the views of the Indian Health Service or other funding agencies. A complete list of centers, investigators, and staff participating in the Diabetes Prevention Program can be found in the Appendix.
Address correspondence to: Diabetes Prevention Program Research Group, Diabetes Prevention Program Coordinating Center, Biostatistics Center, The George Washington University, 6110 Executive Blvd., Suite 750, Rockville, MD 20852. E-mail: [email protected]
